FDA inspection
Lupin Limited: FDA inspection ending Mar 7, 2026
FDA inspection 1309892 · Voluntary Action Indicated (VAI) · Ankleshwar
Key facts
| Inspection ID | 1309892 |
|---|---|
| Firm | Lupin Limited |
| FEI number | 3002807510 |
| Address | Plot no. 09, 123, 123/1, 124 & 125 G.I.D.C. Industrial Estate |
| City | Ankleshwar |
| Fiscal year | 2026 |
| Inspection end date | Mar 7, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data